Streetbeat News

Earnings

BITF

Bitfarms (NASDAQ:BITF) reported Q2 losses of $(0.10) per share, missing the analyst consensus estimate of $(0.05) by 100%. However, the company's quarterly sales of $35.48 million beat the estimate of $34.10 million by 4.04%.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:06 am

TWKS

Thoughtworks Holding (NASDAQ:TWKS) reported Q2 earnings of $0.03 per share, missing the analyst consensus estimate of $0.04 by 25%. This is a 72.73% decrease from the same period last year. The company also reported quarterly sales of $287.21 million, missing the analyst consensus estimate of $301.50 million by 4.74%. This is a 13.52% decrease from the same period last year.

Portfolio Pulse from saritha@benzinga.com

August 08, 2023 | 11:05 am

XERS

Xeris Biopharma has revised its FY23 revenue outlook to $145M - $165M, up from the previous range of $135M to $165M. The company also reduced its cash utilization range to $57M to $67M and improved its year-end cash range to $55M to $65M. Xeris expects to reach cash flow breakeven point in the fourth quarter.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:05 am

FOLD

Amicus Therapeutics reported Q2 losses of $(0.15) per share, missing the analyst consensus estimate of $(0.12) by 25%. However, the company's quarterly sales of $94.50 million beat the estimate of $89.87 million by 5.16%. This represents a 17.06% increase over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:05 am

EVBG

Everbridge has projected its Q3 adjusted EPS to be between $0.42-$0.43, which is in line with the estimated $0.43. However, the company's revenue forecast of $113.5M-$114M falls short of the estimated $117.52M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:05 am

NYT

New York Times (NYSE:NYT) reported Q2 earnings of $0.38 per share, beating the analyst consensus estimate of $0.21 by 80.95%. This is a 58.33% increase from the same period last year. The company also reported quarterly sales of $590.90 million, beating the analyst consensus estimate of $578.14 million by 2.21%, a 6.34% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:05 am

NXST

Nexstar Media Gr (NASDAQ:NXST) reported Q2 earnings of $2.64 per share, missing the analyst consensus estimate of $2.88 by 8.33 percent. This is a 52.52 percent decrease from the same period last year. The company also reported quarterly sales of $1.24 billion, missing the analyst consensus estimate of $1.25 billion by 0.72 percent, a 0.40 percent decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:05 am

MCRB

Seres Therapeutics reported Q2 earnings of $0.36 per share, missing the analyst consensus estimate of $0.55 by 34.55%. However, the company's quarterly sales of $126.47 million beat the estimate of $125.50 million by 0.77%. This represents a 151.43% increase in earnings and a 10.3K% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:04 am

ADCT

ADC Therapeutics (NYSE:ADCT) reported Q2 adjusted losses of $(0.37) per share, beating the analyst consensus estimate of $(0.44) by 15.91%. However, the company's quarterly sales of $19.28 million missed the analyst consensus estimate of $34.77 million by 44.55%.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:04 am

BR

Broadridge Financial Solutions (NYSE:BR) reported Q4 adjusted earnings of $3.21 per share, beating the analyst consensus estimate of $3.10 by 3.55%. This is a 21.13% increase from the same period last year. However, the company's quarterly sales of $1.84 billion missed the analyst consensus estimate of $1.89 billion by 2.49%, though it's a 6.73% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:04 am